Social Media Ideas for Drug Regulation

FDA Regulations to Establish Minimum CGMP Requirements for Manufacturing, Packaging, Labeling, and Holding of Dietary Su...

On June 18, 2026, the Food and Drug Administration (“FDA”) announced the submission of a proposed collection of information to the Office of Management and Budget (“OMB”) pertainin...

At the Half: No Free Kicks in FDA’s 2026 Enforcement

As the World Cup has captured the attention of viewers around the globe, so has the Food and Drug Administration (FDA) when it comes to taking enforcement action against regulated...

Riders on the Storm Part 2: The Drug Provisions

By Jennifer D. Newberger & Sara W. Koblitz & Deborah L. Livornese & Dara Katcher Levy & Mark A. Tobolowsky & Kalie E. Richardson & Riëtte van Laack & Ma...

Brand Name Extensions by Pharma May Finally Be Receiving Scrutiny? 

On July 6, the Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO), published a notice inviting comments on the use of brand name extensions...

Hi, I’m With the Government and I’d Like to Ask You a Question: What State-Licensed Medical Marijuana Operators Need to...

If you’re familiar with operators in the marijuana industry in the United States, you understand that they can be a paranoid bunch — and often with very good reasons. After all, th...

<![CDATA[What Pharma Investors Should Expect in the Current Regulatory Environment]]>

FDA Proposes Long-Awaited Rule to Require Foreign Tobacco Manufacturers to Register Establishments and List Products

On June 26, 2026, the U.S. Food and Drug Administration (FDA), Center for Tobacco Products (CTP), announced a proposed rule titled “Establishment Registration and Product Listing f...

<![CDATA[What Does the Regulatory Landscape Look Like From the Other Side of FDA?]]>

<![CDATA[The Impact of Strict Oversight on DTC Prescription Drug Ads]]>

<![CDATA[The Push at FDA to Tighten Oversight on DTC Prescription Drug Ads]]>

2026 Regulatory Agenda Released – Updates Information Regarding GRAS Rulemaking

Government Tightens Drug Import Rules to Fight Fake Medicines

The government has halted parallel importation of medicines and other health technologies, seeking to tighten oversight of pharmaceutical imports and shield Kenyans from substandar...

<![CDATA[FDA's Timeline for DTC Prescription Drug Ad Oversight]]>

Duale Directs Fresh Registration of All Pharmacies & Drug Suppliers

Duale said the reforms are intended to strengthen pharmaceutical governance, combat counterfeit medicines and ensure compliance with national health regulations.

Cough syrups to be available only with doctor's prescription as govt strengthens regulatory oversight

New Delhi, June 16: Amid drug quality and patient safety concerns, the Union Health ministry has amended rules to prohibit sale of syrups, including cough syrups, without a doctor'...

<![CDATA[The Regulatory Landscape for Rare Pediatric Diseases]]>

Cough Syrups To Be Available Only With Doctor’s Prescription As Govt Strengthens Regulatory Oversight

NEW DELHI : Amid drug quality and patient safety concerns, the Union Health ministry has amended rules to prohibit sale of syrups, including cough syrups, without a doctor’s prescr...

Regulation: Withdrawn MAA regulatory instructions (RI)

RIs will be issued by the MAA to provide direction, and have the same authority as MAA regulation.

State Marijuana Products Can Not Enter Schedule III Without Demonstrating the Chemical Consistency Required by Federal R...

"MMJ Calls on DEA and the Courts to Explain How State Marijuana - Hemp Products Can Enter the US supply chain or even Schedule III Without Demonstrating the Chemical Consistency Re...

Centre bans manufacture, sale and distribution of 16 Fixed-Dose Combinations (FDCs) in 'public interest'

Srinagar, June 20: The Union Ministry of Health and Family Welfare announced complete ban on manufacture, sale and distribution of 16 Fixed Dose Combinations (FDCs) citing public h...

State Regulation of PBMs Subject to Robust Legal Challenges

<![CDATA[FDA Pauses Release of New CRL’s Following Citizen’s Petition ]]>

Regulation: MAA regulatory instructions (RI)

RIs will be issued by the MAA to provide direction, and have the same authority as MAA regulation

<![CDATA[The Evolving Biopharma Regulatory Landscape: Q&A with Harpreet Singh, MD]]>